Search

Your search keyword '"Citera, Gustavo"' showing total 454 results

Search Constraints

Start Over You searched for: Author "Citera, Gustavo" Remove constraint Author: "Citera, Gustavo"
454 results on '"Citera, Gustavo"'

Search Results

104. Depression is a major driver of functional capacity in patients with rheumatoid arthritis regardless of disease activity

105. Una nueva herramienta para valorar la calidad de vida de pacientes con artritis reumatoidea que no requiere licencia: el cuestionario QOL-RA II (Quality of Life-Rheumatoid Arthritis Scale-II)

108. Efficacy, Safety, and Immunogenicity of Biosimilar Etanercept (Enerceptan) Versus Its Original Form in Combination With Methotrexate in Patients With Rheumatoid Arthritis: A Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study.

109. Depression Is a Major Determinant of Functional Capacity in Rheumatoid Arthritis.

112. Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis

113. THU0649 PHENOTYPIC CLUSTERS OF RHEUMATIC/SYSTEMIC IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES (IMMUNOCANCER INTERNATIONAL REGISTRY)

114. The Depression is a major determinant of functional capacity in patients with rheumatoid arthritis, regardless of disease activity

115. THU0628 IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES. BIG DATA ANALYSIS OF 13,051 CASES (IMMUNOCANCER INTERNATIONAL REGISTRY)

116. SAT0631 CRITERION VALIDITY AND CUT-OFFS OF THE FLARE ASSESSMENT IN RHEUMATOID ARTHRITIS (FLARE-RA) QUESTIONNAIRE: INTERNATIONAL COLLABORATION

117. A new tool to assess the quality of life of patients with rheumatoid arthritis that does not require a license: the QOL-RA II (Quality Of Life-Rheumatoid Arthritis Scale-II) questionnaire

118. Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis

119. Retraction Note: Quality of life of patients with rheumatoid arthritis in Argentina: reliability, validity, and sensitivity to change of a Spanish version of the Rheumatoid Arthritis Quality of Life questionnaire

122. Frequency of human leukocyte antigens class II-DR alleles (HLA-DRB1) in Argentinian patients with early arthritis

123. Validación del índice QOL-RA (Quality of Life-Rheumatoid Arthritis) en una cohorte argentina de pacientes con artritis reumatoidea

125. Oral Abstracts 7: RA Clinical * O37. Long-Term Outcomes of Early RA Patients Initiated with Adalimumab Plus Methotrexate Compared with Methotrexate Alone Following a Targeted Treatment Approach

126. Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort

127. Effects of Long‐Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104‐Week Results From a Randomized, Placebo‐Controlled Study

130. Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort

134. Frequency of human leukocyte antigens class II-DR alleles (HLA-DRB1) in Argentinian patients with early arthritis.

135. Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis.

136. Tuberculin test conversion in patients with chronic inflammatory arthritis receiving biological therapy.

137. Tuberculin test conversion in patients with chronic inflammatory arthritis receiving biological therapy.

138. Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry.

139. Clinical responses by baseline RA disease duration in the AMPLE (abatacept versus adalimumab comparison in biologic-nave RA patients with background methotrexate) trial: 2-year results

140. Q222R polymorphism in the DNAse I gene is not associated with susceptibility to rheumatoid arthritis or to disease course in an Argentine patient cohort

142. Frecuencia de mortalidad en pacientes con artritis reumatoidea en un centro de reumatología de Argentina

143. Comorbidities in Argentine patients with axial spondyloarthritis: Is nephrolithiasis associated with this disease?

144. Efficacy and safety of etanercept in patients from Latin America, Central Europe and Asia with early non‐radiographic axial spondyloarthritis.

145. Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study

149. Certolizumab para el tratamiento de un paciente con artritis reumatoidea refractaria a múltiples agentes biológicos

150. Effects of cigarette smoking on early arthritis: a cross-sectional study—data from the Argentine Consortium for Early Arthritis (CONAART)

Catalog

Books, media, physical & digital resources